MARKET

INOV

INOV

Inovalon Hldg
NASDAQ

Real-time Quotes | Nasdaq Last Sale

24.74
+0.08
+0.32%
Opening 13:27 09/22 EDT
OPEN
24.72
PREV CLOSE
24.66
HIGH
24.97
LOW
24.08
VOLUME
105.09K
TURNOVER
--
52 WEEK HIGH
26.75
52 WEEK LOW
13.39
MARKET CAP
3.84B
P/E (TTM)
310.03
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Inovalon to Host Virtual Client Congress September 21 – 23, 2020
Scott Gottlieb, M.D., Medical Policy Expert and Former Commissioner of the FDA to Deliver Keynote Address Focusing on Data-Driven Strategies to Improve Patient OutcomesBOWIE, Md., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven
GlobeNewswire · 09/15 11:55
Inovalon to Participate in a Virtual Fireside Chat at Citi’s Global Technology Conference on September 10, 2020
BOWIE, Md., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D., chief executive officer and chairman of the board of Inovalon, and Jonathan R. Boldt, chief financial officer
GlobeNewswire · 09/08 11:55
What Type Of Shareholders Own The Most Number of Inovalon Holdings, Inc. (NASDAQ:INOV) Shares?
Simply Wall St. · 09/07 20:36
Inovalon (INOV) Investor Presentation - Slideshow
The following slide deck was published by Inovalon Holdings, Inc. in conjunction with this event..
Seeking Alpha - Article · 08/25 19:35
Citigroup Maintains Neutral on Inovalon Holdings, Raises Price Target to $26
Citigroup maintains Inovalon Holdings (NASDAQ:INOV) with a Neutral and raises the price target from $24 to $26.
Benzinga · 08/11 11:33
Citigroup Maintains Neutral on Inovalon Holdings, Raises Price Target to $26
Citigroup maintains Inovalon Holdings (NASDAQ:INOV) with a Neutral and raises the price target from $24 to $26.
Benzinga · 08/11 11:33
Inovalon Holdings Option Alert: Sep 18 $25 Calls at the Ask: 1000 @ $1.65 vs 53 OI; Ref=$24.42
Benzinga · 07/30 14:07
Inovalon Holdings, Inc. 2020 Q2 - Results - Earnings Call Presentation
Seeking Alpha · 07/30 04:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average INOV stock price target is 26.00 with a high estimate of 31.00 and a low estimate of 13.00.
EPS
Institutional Holdings
Institutions: 223
Institutional Holdings: 53.22M
% Owned: 34.26%
Shares Outstanding: 155.35M
TypeInstitutionsShares
Increased
62
3.67M
New
54
420.14K
Decreased
46
3.07M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
IT Services & Consulting
+0.31%
Software & IT Services
+0.85%
Key Executives
Chairman/Chief Executive Officer/Director
Keith Dunleavy
President
Robert Wychulis
Chief Financial Officer
Jonathan Boldt
Chief Operating Officer
Jason Capitel
Chief Administrative Officer
Peter De Bock
Director
Mark Pulido
Independent Director
Denise Fletcher
Other
June D. Duchesne
Independent Director
William Green
Independent Director
Andre Hoffmann
Independent Director
Isaac Kohane
Independent Director
Lee Roberts
Independent Director
William Teuber
Independent Director
Mark A. Pulido
  • Dividends
  • Splits
  • Insider Activity
No Data

Analyst Price Target

The average INOV stock price target is 26.00 with a high estimate of 31.00 and a low estimate of 13.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About INOV
Inovalon Holdings, Inc. (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Through the Inovalon ONE Platform, the Company enables to interconnect with the healthcare ecosystem, aggregate and analyze data in real-time, and empower the application of resulting insights. Leveraging data interconnectivity capabilities, unparalleled data sets, analytics, data-driven intervention systems. The Company serves clients across the healthcare industry, which includes health plans and provider organizations, pharmaceutical, medical device, and diagnostics companies. It provides technology that supports approximately 500 healthcare organizations. Inovalon's platforms are informed by data pertaining to more than 941,000 physicians, 483,000 clinical facilities, 243 million Americans and 38 billion medical events.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Inovalon Holdings Inc stock information, including NASDAQ:INOV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INOV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INOV stock methods without spending real money on the virtual paper trading platform.